Document is current

Article History

Received: 20 December 2021

Accepted: 25 May 2022

First Online: 10 June 2022

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all patients for being included in the study. This article does not contain any studies with human or animal subjects performed by any of the authors. The study was approved by relevant local Ethics Boards at each site. For the French site, the study protocol received Institutional Review Board approval by the Comité d’Ethique de la Recherche en Obstétrique et Gynécologie Ethical Review Committee (submission number CEROG 2018-OBS-0707) in 2018. For the Japan site, the study protocol was approved by Institutional Review Board at National Center for Child Health and Development on September 3, 2020 (project number 2020–088). For the Spain site, the study protocol was approved by Ethics Committee for the Hospital Universitario De Torrevieja and Hospital Universitario Del Vinalopo on September 25, 2019.

: Informed consent was obtained from all patients for being included in the study.

: Patricia Winters and Kirsten Curnow are employed by and own stock in Illumina, Inc. Alexandra Benachi, Maria Mar Gil, Belen Santacruz, Miyuki Nishiyama, Fuyuki Hasegawa, and Haruhiko Sago declare that they have no conflicts of interest.